SBK Financial’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-12
Closed -$7.48K – 207
2026
Q2
$7.48K Buy
+12
New +$8.17K ﹤0.01% 191

Other funds holding REGN

SBK Financial's REGN Position: Q3 2026 in Review

SBK Financial sold out of Regeneron Pharmaceuticals (REGN) in Q3 2026, closing a stake of 12 shares — an estimated $7.48K sold.

SBK Financial first reported a position in REGN in Q2 2026 and held it in 1 quarter. The position peaked at $7.48K in Q2 2026. 1,432 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • SBK Financial reported no remaining Regeneron Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • SBK Financial sold 12 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $7.48K.
  • SBK Financial first reported a position in Regeneron Pharmaceuticals in Q2 2026 and held it in 1 quarter.
  • SBK Financial's Regeneron Pharmaceuticals position peaked at $7.48K in Q2 2026.
  • 1,432 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on SBK Financial's 13F filing for Q3 2026, filed 2 Nov 2026.